http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27582289

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 230
issn 1365-7852
1476-5608
issueIdentifier 3
pageRange 222-230
publicationName Prostate Cancer and Prostatic Diseases
startingPage 222
bibliographicCitation Azzouni F, Mohler J. Role of 5α-reductase inhibitors in benign prostatic diseases. Prostate Cancer Prostatic Dis. 2012 Sep;15(3):222–30. doi: 10.1038/pcan.2012.1. PMID: 22333687.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a51edbf42a4c214179b44544ede93df0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c8725d2176cb60a2bb48bff1efc0922a
date 2012-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/22333687
https://doi.org/10.1038/pcan.2012.1
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30139
https://portal.issn.org/resource/ISSN/1476-5608
https://portal.issn.org/resource/ISSN/1365-7852
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Role of 5α-reductase inhibitors in benign prostatic diseases
discusses http://id.nlm.nih.gov/mesh/M0021199
http://id.nlm.nih.gov/mesh/M0545267
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8981
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c582dec943ff7b743aa0691df291cea6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5995

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128760372
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128649586

Total number of triples: 34.